126 related articles for article (PubMed ID: 11131651)
1. In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination.
Paulsen JE; Lützow-Holm C
Anticancer Res; 2000; 20(5B):3485-9. PubMed ID: 11131651
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor.
Paulsen JE; Elgjo K
In Vivo; 2001; 15(5):397-401. PubMed ID: 11695236
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
4. Suramin selectively inhibits carcinoma cell growth that is dependent on extracellular polyamines.
Sandgren S; Belting M
Anticancer Res; 2003; 23(2B):1223-8. PubMed ID: 12820375
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition by polyamine biosynthesis inhibitor DFMO of the growth of transplanted human colon cancer in nude mice].
Wang M
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):335-7. PubMed ID: 1782843
[TBL] [Abstract][Full Text] [Related]
6. Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.
Luk GD; Abeloff MD; McCann PP; Sjoerdsma A; Baylin SB
Cancer Res; 1986 Apr; 46(4 Pt 1):1849-53. PubMed ID: 3004708
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) on the growth of experimental renal adenocarcinoma in mice.
Herr HW; Kleinert EL; Conti PS; Burchenal JH; Whitmore WF
Cancer Res; 1984 Oct; 44(10):4382-5. PubMed ID: 6432312
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
[TBL] [Abstract][Full Text] [Related]
9. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid.
Coffey DC; Kutko MC; Glick RD; Butler LM; Heller G; Rifkind RA; Marks PA; Richon VM; La Quaglia MP
Cancer Res; 2001 May; 61(9):3591-4. PubMed ID: 11325825
[TBL] [Abstract][Full Text] [Related]
11. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
Luk GD; Abeloff MD; Griffin CA; Baylin SB
Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
[TBL] [Abstract][Full Text] [Related]
13. Reduced growth rate of dimethylhydrazine-induced colon tumors in rats.
Tsunoda A; Shibusawa M; Tsunoda Y; Yasuda N; Koike T
Cancer Res; 1992 Feb; 52(3):696-700. PubMed ID: 1732057
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition effect of tumor growth by using celecoxib in combination with oxaliplatin.
Zhao S; Cai J; Bian H; Gui L; Zhao F
Cancer Invest; 2009 Jul; 27(6):636-40. PubMed ID: 19387877
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
[TBL] [Abstract][Full Text] [Related]
16. The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice.
Paulsen JE
Carcinogenesis; 1993 Aug; 14(8):1719-21. PubMed ID: 8353859
[TBL] [Abstract][Full Text] [Related]
17. Failure of tripeptide colon mitosis inhibitor to suppress the cell proliferation of dimethylhydrazine-induced colonic cancers in rats.
Pawlikowski M; Zerek-Mełeń G; Stepień H; Lachowicz A; Winczyk K; Szadowska A
Cytobios; 1993; 76(306-307):151-5. PubMed ID: 8181305
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of colony formation of human renal cell carcinoma in soft agar by the combination of alpha-difluoromethylornithine and recombinant gamma-interferon.
Gohji K; Murao S; Maeda S; Sugiyama T; Kamidono S
Cancer Res; 1986 Dec; 46(12 Pt 1):6264-8. PubMed ID: 3096559
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
